The strategic alliance between Farmalider Group and MASPV will reduce their carbon footprint by 70 tonnes of CO₂ per year, equivalent to saving 63 tonnes of coal and preserving 777 trees annually. In this way, Farmalider Group demonstrates its commitment to the health of both patients and the planet.
Farmalider Group, a benchmark in pharmaceutical innovation, has commissioned its new photovoltaic installation at Laboratorios Edefarm (Valencia), achieving 32% energy self-consumption. This project, developed in collaboration with MASPV, pioneers in self-consumption solutions in Spain, reinforces Farmalider Group’s commitment to sustainability and progress toward a greener future.
This initiative forms part of MASPV’s innovative EMC (Energy Management Contract) collaboration model. MASPV has assumed the initial investment for this 132 kWp plant and will be responsible for the operation and maintenance of the installation, allowing Farmalider Group to focus on its core business without operational distractions.
“The installation of these photovoltaic panels is a key milestone in our journey toward sustainability. This project not only reflects our environmental responsibility, but also our vision of leadership in the implementation of clean technologies within the pharmaceutical sector.”
— Marisa Berenguer
In addition, Farmalider Group is implementing further sustainability measures, such as electric vehicle charging stations available to employees and a management commitment to transition to electric vehicles by 2027.
About Farmalider Group
Founded in 1986, Farmalider Group is a leader in the research, development, and manufacturing of pharmaceutical specialties. Headquartered in Alcobendas, with offices in Barcelona and Miami, the company operates two proprietary manufacturing plants: Toll Pharma, located in Madrid, and Laboratorios Edefarm in Valencia.
Laboratorios Edefarm specializes in the manufacturing, handling, and packaging of pharmaceutical products and food supplements. It operates from 3,000 m² of state-of-the-art facilities, leveraging advanced technology and sustainable practices to deliver high-quality healthcare and nutritional solutions. Edefarm has been part of Farmalider Group since 2022.
Farmalider Group is distinguished by its innovative, patient-centered approach. The company has improved and developed new formats of essential medicines, such as ibuprofen and paracetamol in tablets, suspensions, sticks, injectables (among other pharmaceutical forms), as well as many other innovative, value-added products included in its portfolio.
With more than 160 marketing authorizations in the European Union and over 30 patent families filed worldwide, Farmalider is a reference in pharmaceutical development. Its products are present in more than 80 countries, with plans to expand to 150 countries by 2027. As part of its strategic plan, and as a pioneering company in the healthcare sector, Farmalider Group is also developing innovative projects focused on advanced therapies, aligned with its future innovation strategy centered on biotechnology.
About MASPV
MASPV is a global player in the photovoltaic sector. A pioneer in self-consumption in Spain, the Group has a team of solar energy experts with over 15 years of experience, including engineers and architects, ensuring the highest level of reliability in client projects.
MASPV innovates daily to deliver unique, tailor-made projects, positioning itself as a global benchmark in the engineering, development, construction, and operation of energy efficiency projects. With more than 500 MW deployed worldwide across markets such as China, Japan, Panama, Mexico, Chile, Costa Rica, the Dominican Republic, and Colombia, the company continues to expand its footprint in solar energy. Its main offices are located in Madrid, Panama, Mexico City, Hong Kong, and Beijing.
MASPV’s groundbreaking EMC (Energy Management Contract) model enables companies to reduce energy consumption and achieve more than 50% grid independence without the need to invest in photovoltaic installations. It also offers clients the option to acquire the plant directly over its useful life, under highly competitive conditions compared to more traditional market models. The EMC represents an attractive alternative to the “turnkey” project, in which the client makes the upfront investment—an option also available within MASPV’s portfolio.
MASPV completes its global offering with electric vehicle charging stations and solar panel parking solutions, reaffirming its commitment to delivering maximum energy efficiency to the business sector.
Source: Comunicae
